Management of treatment of
acute coronary syndrome is also valid for Kounis syndrome.
Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in
acute coronary syndrome and in patients with increased troponin in the absence of
acute coronary syndrome.
Strong evidence supports troponins T and I as indicators of increased risk for patients with
acute coronary syndrome, and efforts are underway to determine whether therapeutic intervention can reduce this risk.
Market Analysis: Global
Acute Coronary Syndrome Market
Recurrent
acute coronary syndrome due to coronary artery spasm in different coronary arteries.
Epidemiology of coronary heart disease and
acute coronary syndrome. Ann Transl Med.
A 60-year-old man is seen in your clinic 30 days after he was hospitalized for
acute coronary syndrome (ACS) due to ST-elevation myocardial infarction (STEMI).
On versus off-hour care of patients with
acute coronary syndrome and persistent ST-segment elevation in certified German chest pain units.
Faisal Ahmed talked about
Acute Coronary Syndrome with Cardiogenic shook and stated that coronary reperfusion is the mainstay evidenced based therapy intervention with Coronary Syndrome.
Assiri et al [1] stated that platelet parameters, mainly MPV and PDW are inexpensive lab tests which we detected to be significantly raised in patients suffering from
acute coronary syndrome compared with controls.
The session will focus on various topics namely, Pathophysiology of
acute coronary syndrome; Management of Non-ST-elevation myocardial infarction (NSTEMI) in diabetes patients; Echocardiography for
acute coronary syndrome; Echocardiography for
acute coronary syndrome; How to do a primary Percutaneous Coronary Intervention (PCI); Pharmacoinvasive therapy in STEMI; Ventricular arrhythmias in AMI management; Diabetes in
acute coronary syndrome (theory to practical); Multivessel PCI in
Acute coronary syndrome (ACS); Culprit artery only PCI during STEMI; and 'Non -- CABG' cardiac surgical options in
acute coronary syndrome.
The Odyssey Outcomes trial has met its primary endpoint and was held in around 19,000 patients who had a recent
acute coronary syndrome event, such as a heart attack.
The cohort was part of the Continuous Positive Airway Pressure (CPAP) in Patients With
Acute Coronary Syndrome and Obstructive Sleep Apnea (ISAACC) study, a prior randomized, controlled trial that evaluated the effect of CPAP treatment on new cardiovascular events in patients with an episode of ACS and OSA, reported Alicia Sanchez-de-la-Torre, PhD, of the respiratory department at Hospital Universitari Arnau de Vilanova and Santa Maria in Catalonia, Spain, and her coauthors.
Acute coronary syndrome (ACS) is a very common cause of morbidity and mortality in the U.S., accounting for approximately 1.5 million of hospital discharges and costing more than 150 billion dollars per year according to the American Heart Association [1].
Myocarditis is the commonest underlying aetiology in patients with suspected
acute coronary syndrome with nonobstructive coronary arteries and accounts for up to three quarters of cases in several studies [2, 3].
